Immunohistochemical staining of the rebiopsied tissue before afatinib treatment showed that tumor cells expressed high levels of PDL1, and CD8‐positive effector T cells infiltrated the tumor stroma but did not respond to anti‐PD‐L1 antibody. Here, CD8A is linked to neoplasm.